"Catching lung cancer earlier helps us to be able to treat the patient and have a much higher survival rate. The Galaxy System™ allows us to be able to go after these very small peripheral lung lesions with confidence.” - Dr. Krish Bhadra Find out how Galaxy can improve your diagnostic confidence at AABIP 2024. 🔗: https://hubs.ly/Q02Lywnd0 #NoahMedical #GalaxySystem #AABIP2024 #LungCancer #Bronchoscopy
Noah Medical
Medical Equipment Manufacturing
San Carlos, California 23,927 followers
Building the future of medical robotics
About us
Noah Medical is building the future of medical robotics. Our next generation robotic platform targets early diagnosis and treatment of patients across multiple indications. Based in Silicon Valley and backed by well-known institutional investors, our incredibly talented team of 70 engineers, innovators and industry leaders brings years of experience from the top healthcare companies in the world.
- Website
-
http://www.noahmed.com
External link for Noah Medical
- Industry
- Medical Equipment Manufacturing
- Company size
- 201-500 employees
- Headquarters
- San Carlos, California
- Type
- Privately Held
- Founded
- 2018
Locations
-
Primary
San Carlos
San Carlos, California 94070, US
Employees at Noah Medical
-
Madhukar Verma
Head of Software at Noah Medical
-
Andrew Woodward
-
Steve Lamont
Investor/Advisor for Silicon Valley Startups. Helping technology companies tell their compelling stories to investors, customers, and partners.
-
Mary G.
MedTech Executive, Business Development, Board Observer, Angel Investor, Ex-Abbott, Ex-Intuitive, Global Medical Device
Updates
-
The Journal of Respirology has published clinical trial data demonstrating the benefits of Noah Medical’s Galaxy System™. Learn more about the results from the FRONTIER study here: Improve your diagnostic confidence. Find out how at AABIP 2024. 🔗: https://hubs.ly/Q02LykkR0 #NoahMedical #GalaxySystem #LungCancer #Bronchoscopy #AABIP2024
-
Visualize. Target. Confirm. "Knowing that you got what you went after is paramount to a successful procedure. With Galaxy, I get confidence at the time of diagnosis. I’ve got a tool that provides precision and accuracy for lung cancer diagnosis that I never had until now." - Stephen Kovacs, DO, FCCP For more information: https://hubs.ly/Q02LwzhZ0 #NoahMedical #GalaxySystem #LungCancer #Bronchoscopy #AABIP2024
-
Seeing is believing. "Galaxy has allowed me to get to smaller nodules. I didn’t before with other devices." - Dr. Sean Callahan, Prisma Health Find out how Galaxy can improve your diagnostic confidence at AABIP 2024. https://hubs.ly/Q02KzXd_0 #NoahMedical #LungCancer #Bronchoscopy #AABIP2024
-
Now The Lesion is in Sight. "TiLT Technology, you know with confidence that you’re driving out to the lesion, and you’re actually in it." -Dr. Krish Bhadra Find out how Galaxy can improve your diagnostic confidence at AABIP 2024. https://hubs.ly/Q02K2dqk0 #NoahMedical #LungCancer #Bronchoscopy #AABIP24
-
Tool-in-Lesion is now in sight. "There’s a reason why people who use the Galaxy are having unbelievable success. It’s because the image integration that is TiLT, allows you to target. To know for sure I'm in the lesion" - Dr. D. Kyle Hogarth, MD, FCCP Find out how Galaxy can improve your diagnostic confidence at noahmed.com/AABIP2024 #NoahMedical #LungCancer #Bronchoscopy #AABIP24
-
Increasing diagnostic yield in bronchoscopy is hard; The Galaxy System can help. "With Galaxy, I get confidence the time of diagnosis, because I have fully integrated imaging. I’ve got a tool that provides precision and accuracy for lung cancer diagnosis that I never had until now." - Stephen Kovacs, DO, FCCP Find out how Galaxy can improve your diagnostic confidence at noahmed.com/AABIP2024 #NoahMedical #LungCancer #Bronchoscopy #AABIP24
-
Join us to experience the Galaxy System™ with TiLT Technology™ at the American Association for Bronchoscopy and Interventional Pulmonology (AABIP) 2024 meeting on August 22 - 24, in Charlotte, NC. Learn more: https://hubs.ly/Q02H_rh50 #NoahMedical #GalaxySystem #AlwaysInSight #LungCancer #Bronchoscopy #iiRAB #healthcare #AABIP
-
Dr. D. Kyle Hogarth, MD, FCCP with an excellent example of how The Galaxy System™ with TiLT Technology™ is helping him and his team UChicago Medicine overcome CT-to-body divergence, improve overall diagnostic yield and provide positive patient outcomes. This proprietary technology is designed to allow for real-time navigation updates and guidance in all areas of the lung, including an augmented fluoro feature designed to overlay a graphical representation of the target lesion during live fluoro video to help locate non-visual lesions. #NoahMedical #GalaxySystem #AlwaysInSight #LungCancer #Bronchoscopy #iiRAB #healthcare
Great case for a GGO today using Noah Galaxy. 16mm LUL with average HF of -586. Navigated in 20 seconds and then corrected the CTBD inherent in all robotic platforms (EMN and shape sensing) using TILT (see image 1 below). This updates in real time the lesion location and gives augmented fluoroscopy. There was no airway into this lesion so we used a Medtronic needle to make a hole targeting the lesion using augmented Fluro and the Galaxy targeting system (see image 2 below). This aspirate was positive for tumor (see image 3 below). Then, because we didn't have to blind ourselves and remove the optics, we could see the hole we made that lead directly into the tumor and pass our forceps in for larger biopsies (see image 4 below). the TBBx tissue was positive for tumor on ROSE but also the VanGogh system (see image 5 below). Total radiation was 19mGy for the entire case (radiation used for 1 TILT, 2 aspirates, 4 biopsies, and a fiducial placed). Disposable scope thrown away, minimal radiation dose to the patient and my team, and no additional expensive mobile cone beam required to make my robot actually work. True Image Integrated Robotic Targeting makes all the difference. Noah Medical Aquyre Biosciences, Inc.
-
The final results and high diagnostic yield from Noah Medical’s FRONTIER Study were recently covered by Healio. https://hubs.ly/Q02H7CRf0 Originally published in the Official Journal of the Asian Pacific Society of Respirology, the study found that Galaxy achieved 100% successful navigation to small lesions in the lung periphery, diagnostic yield up to 94.7% (intermediate) and 100% tool-in-lesion accuracy. Importantly, this study is also noteworthy because it demonstrates that the use of Galaxy can be rapidly scaled to improve lung cancer detection rates even in places where physicians have limited experience with robotic systems. Thanks to Dr. Tajalli Saghaie for his important work in completing this clinical trial. #NoahMedical #LungCancer #RoboticBronchoscopy #EarlyDetection #DiagnosticYield